Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 USD | -3.57% | -14.76% | +33.71% |
Financials (USD)
Sales 2024 * | 1.19B | Sales 2025 * | 1.47B | Capitalization | 2.64B |
---|---|---|---|---|---|
Net income 2024 * | 24M | Net income 2025 * | 52M | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | 218M | Net cash position 2025 * | 382M | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
162
x | P/E ratio 2025 * |
55.1
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83% |
Latest transcript on Hims & Hers Health, Inc.
1 day | -3.57% | ||
1 week | -14.76% | ||
Current month | -23.08% | ||
1 month | -23.91% | ||
3 months | +43.03% | ||
6 months | +96.69% | ||
Current year | +33.71% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 57 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 82 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 237 M€ | +0.46% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 11.9 | -3.57% | 4,827,615 |
24-04-18 | 12.34 | -0.56% | 3,549,539 |
24-04-17 | 12.41 | -2.21% | 3,898,714 |
24-04-16 | 12.69 | -4.01% | 7,022,686 |
24-04-15 | 13.22 | -5.30% | 5,292,525 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.71% | 2.64B | |
-39.77% | 2.23B | |
+23.62% | 502M | |
+42.77% | 467M | |
-63.32% | 153M |
- Stock Market
- Equities
- HIMS Stock